A
Acella Pharmaceuticals
Acella agreed to a $41.4 million settlement over false advertising claims related to NP Thyroid medication.
ClosedUnited States-wideClaim status: Closed on November 30, 2024Payout: $50No longer claimable
About this settlement
Settlement for false advertising claims regarding the active ingredient content in NP Thyroid medication.
This settlement resolves claims that Acella Pharmaceuticals falsely advertised the NP Thyroid medication as containing a specified amount of the active ingredient. Eligible individuals who received NP Thyroid prescriptions during the specified period may claim $50 each.
Who qualifies
- Individuals who received a dispensed prescription for NP Thyroid between May 12, 2018 and April 30, 2021.
- Eligibility applies regardless of whether the NP Thyroid lots were recalled.
$50
Claim status: Closed on November 30, 2024